Bharat Biotech’s Covaxin 3rd phase clinical trials show 77.8% overall efficacy rate; vaccine 65.2%…
In a significant development, indigenously developed Bharat Biotech's Coronavirus vaccine Covaxin has been found to be 77.8 percent effective against symptomatic Coronavirus infections, the result of the third phase of clinical trials of…